Key Genetic Components of Fibrosis in Diabetic Nephropathy: An Updated Systematic Review and Meta-Analysis

Int J Mol Sci. 2022 Dec 5;23(23):15331. doi: 10.3390/ijms232315331.

Abstract

Renal fibrosis (RF) constitutes the common end-point of all kinds of chronic kidney disease (CKD), regardless of the initial cause of disease. The aim of the present study was to identify the key players of fibrosis in the context of diabetic nephropathy (DN). A systematic review and meta-analysis of all available genetic association studies regarding the genes that are included in signaling pathways related to RF were performed. The evaluated studies were published in English and they were included in PubMed and the GWAS Catalog. After an extensive literature review and search of the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, eight signaling pathways related to RF were selected and all available genetic association studies of these genes were meta-analyzed. ACE, AGT, EDN1, EPO, FLT4, GREM1, IL1B, IL6, IL10, IL12RB1, NOS3, TGFB1, IGF2/INS/TH cluster, and VEGFA were highlighted as the key genetic components driving the fibrosis process in DN. The present systematic review and meta-analysis indicate, as key players of fibrosis in DN, sixteen genes. However, the results should be interpreted with caution because the number of studies was relatively small.

Keywords: diabetic nephropathy; genes; meta-analysis; renal fibrosis; review.

Publication types

  • Meta-Analysis
  • Systematic Review
  • Review

MeSH terms

  • Diabetes Mellitus*
  • Diabetic Nephropathies* / genetics
  • Fibrosis
  • Genetic Association Studies
  • Humans
  • Renal Insufficiency, Chronic*
  • Signal Transduction

Grants and funding

This research received no external funding.